MiMedx Group, Inc. (MDXG) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About MiMedx Group, Inc.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that…
Source: Yahoo Finance
Sector & Industry
MiMedx Group, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
MiMedx Group, Inc. at a Glance
| Company | MiMedx Group, Inc. |
| Ticker | MDXG |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $4.57 |
| Market cap | $666.13M |
| P/E ratio (trailing) | 114.25 |
| EPS (trailing) | $0.04 |
| 52-week high | $7.97 |
| 52-week low | $3.03 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.42 |
| Return on equity (ROE) | 2.88% |
| Debt-to-equity | 7.97% |
| Average volume | 1.27M |
| Shares outstanding | 145.76M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 808 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is MiMedx Group, Inc.'s current P/E ratio?
- MiMedx Group, Inc. (MDXG) has a trailing P/E ratio of 114.25 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is MiMedx Group, Inc.'s market capitalisation?
- MiMedx Group, Inc.'s market cap is $666.13M based on our latest snapshot. See how it ranks by market cap →
- What is MDXG's 52-week range?
- Over the past 52 weeks, MDXG has traded between $3.03 and $7.97. What does the 52-week range mean? →
- How volatile is MiMedx Group, Inc. compared to the market?
- MiMedx Group, Inc. has a beta of 1.42, meaning it has historically moved more than the broader market. What does beta measure? →
- Does MiMedx Group, Inc. pay a dividend?
- MiMedx Group, Inc. does not currently pay a dividend according to our latest data.
- What exchange is MDXG listed on?
- MDXG is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is MiMedx Group, Inc. in?
- MiMedx Group, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →